Immunomodulation in leukemia: cellular aspects of anti-leukemic properties
págs. 1-10
págs. 11-20
Margarita Majem, Jesús R. Hernández Hernández, Florentino Hernando Trancho, Núria Rodríguez de Dios, Amalia Sotoca, Juan Carlos Trujillo Reyes, Iván Vollmer Torrubiano, Roberto Carlos Delgado Bolton, Mariano Provencio Pulla
págs. 21-36
The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose–response of randomized clinical trials
J. Rahmani, N. Manzari, J. Thompson, S.K. Gudi, M. Chhabra, G. Naik, S.M. Mousavi, H.K. Varkaneh, C. Clark, Y. Zhang
págs. 37-49
Qianqian Xiong, Xuezhi Zhou, Zhenyu Liu, Chuqian Lei, Ciqiu Yang, Mei Yang, Liulu Zhang, Teng Zhu, Xiaosheng Zhuang, Changhong Liang, Zaiyi Liu, Jie Tian, Kun Wang
págs. 50-59
págs. 60-69
págs. 70-80
Unveiling the mechanisms of immune evasion in pancreatic cancer: may it be a systemic inflammation responsible for dismal survival?
págs. 81-90
Response to immunohistochemical markers’ conversion after neoadjuvant chemotherapy in breast cancer patients: association between imaging and histopathologic analysis
págs. 91-102
págs. 103-110
MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis
H.Q. Mu, Y. He, S.B. Wang, S. Yang, Y.J. Wang, C.J. Nan, Y.F. Bao, Q.P. Xie, Y.H. Chen
págs. 111-121
Two-dimensional versus three-dimensional laparoscopic gastrectomy in surgical efficacy for gastric cancer: a systematic review and meta-analysis
págs. 122-129
Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP)
Pedro Antonio Cascales Campos, Víctor López López, Juan Torres Melero, Álvaro Arjona Sánchez, F.C. Muñoz Casares, Pedro Barrios Sánchez, Rafael Morales Soriano, Fernando Pereira Pérez, Pere Bretcha Boix, Luis González Bayón, Santiago González Moreno, José Gil Martínez
págs. 130-136
Myeloid leukemia with high EVI1 expression is sensitive to 5-aza-2′-deoxycytidine by targeting miR-9
págs. 137-143
Efficacy and safety of a simplified SBRT regimen for central and peripheral lung tumours
A. Román, Alberto Pérez Rozos, Ana M. Otero Romero, Carlos Jódar López, Isabel García Rios, Yolanda Lupiáñez Pérez, José Antonio Medina Carmona, J. Gómez Millán
págs. 144-150
Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study
B.G. Salas Salas, D.J. Domínguez Nuez, R. Cabrera, L. Ferrera Alayón, Marta Lloret Sáez-Mravo, Pedro Lara Jiménez
págs. 151-157
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience
A. Parisi, E. Palluzzi, A. Cortellini, T. Sidoni, V. Cocciolone, P. Lanfiuti Baldi, G. Porzio, C. Ficorella, K. Cannita
págs. 158-162
Is it time to change follow-up recommendations in colorectal cancer?
Elena Asensio Martínez, L. Gómez González, R. Morales Giménez, F.J. Pelegrín Mateo, M. Fernández Cruz, Javier Gallego Plazas
págs. 163-164
© 2001-2024 Fundación Dialnet · Todos los derechos reservados